Although the CP2c mRNA was upregulated in cancer tissues over that in the adjacent normal tissues, its level was low in YY1 high cancers, which is consistent with previous reports that YY1 directly interacts with CP2c and suppresses the transcriptional activity of CP2c (24). The gene discussed is YY1; the disease is cancer.